Goldman Sachs Group Inc Stereotaxis, Inc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 111,980 shares of STXS stock, worth $320,262. This represents 0.0% of its overall portfolio holdings.
Number of Shares
111,980
Previous 200,050
44.02%
Holding current value
$320,262
Previous $352,000
32.67%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding STXS
# of Institutions
94Shares Held
42MCall Options Held
21.9KPut Options Held
18.6K-
Dafna Capital Management LLC Los Angeles, CA13.7MShares$39.1 Million8.43% of portfolio
-
Lagoda Investment Management, L.P. New York, NY4.69MShares$13.4 Million5.81% of portfolio
-
Black Rock Inc. New York, NY3.54MShares$10.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.3MShares$9.45 Million0.0% of portfolio
-
Arbiter Partners Capital Management LLC New York, NY2.85MShares$8.16 Million14.02% of portfolio
About Stereotaxis, Inc.
- Ticker STXS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,790,096
- Market Cap $214M
- Description
- Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...